PortfoliosLab logoPortfoliosLab logo
ALHC vs. CLOV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ALHC vs. CLOV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alignment Healthcare Holdings, LLC (ALHC) and Clover Health Investments, Corp. (CLOV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ALHC achieves a -31.54% return, which is significantly lower than CLOV's 81.70% return.


ALHC

1D
-7.14%
1M
-43.19%
6M
-40.93%
YTD
-31.54%
1Y
-1.02%
3Y*
27.98%
5Y*
-8.40%
10Y*
ALL TIME*
-6.20%

CLOV

1D
-1.39%
1M
-18.82%
6M
98.60%
YTD
81.70%
1Y
48.26%
3Y*
47.89%
5Y*
-12.08%
10Y*
ALL TIME*
-13.03%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$110.51M$106.48M$115.77M
$15.75M$20.89M$32.17M

ALHC vs. CLOV - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ALHC
Alignment Healthcare Holdings, LLC
-31.54%75.56%30.66%-26.79%-16.36%-26.19%
CLOV
Clover Health Investments, Corp.
81.70%-25.40%230.85%2.43%-75.01%-52.43%

Correlation

The correlation between ALHC and CLOV is 0.33, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.33

Correlation (3Y)
Balances recent behavior with more history.

0.28

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.36

Correlation (All Time)
Calculated using the full available price history since Mar 26, 2021

0.34

Fundamentals

Market Cap

ALHC:

$2.80B

CLOV:

$2.21B

EPS

ALHC:

$0.19

CLOV:

-$0.11

PS Ratio

ALHC:

0.62

CLOV:

1.00

PB Ratio

ALHC:

10.93

CLOV:

6.57

Total Revenue (TTM)

ALHC:

$4.58B

CLOV:

$2.21B

Gross Profit (TTM)

ALHC:

$248.98M

CLOV:

$939.14M

EBITDA (TTM)

ALHC:

$86.51M

CLOV:

-$55.21M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ALHC vs. CLOV — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ALHC
ALHC Risk / Return Rank: 4242
Overall Rank
ALHC Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
ALHC Sortino Ratio Rank: 4242
Sortino Ratio Rank
ALHC Omega Ratio Rank: 4343
Omega Ratio Rank
ALHC Calmar Ratio Rank: 4141
Calmar Ratio Rank
ALHC Martin Ratio Rank: 4141
Martin Ratio Rank

CLOV
CLOV Risk / Return Rank: 6464
Overall Rank
CLOV Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
CLOV Sortino Ratio Rank: 6767
Sortino Ratio Rank
CLOV Omega Ratio Rank: 6666
Omega Ratio Rank
CLOV Calmar Ratio Rank: 6363
Calmar Ratio Rank
CLOV Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ALHC vs. CLOV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Alignment Healthcare Holdings, LLC (ALHC) and Clover Health Investments, Corp. (CLOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ALHCCLOVDifference
Sharpe ratioReturn per unit of total volatility

-0.71

Sortino ratioReturn per unit of downside risk

-1.02

Omega ratioGain probability vs. loss probability

1.06

1.18

-0.12

Calmar ratioReturn relative to maximum drawdown

-0.02

0.87

-0.90

Martin ratioReturn relative to average drawdown

-0.07

1.63

-1.70

ALHC vs. CLOV - Sharpe Ratio Comparison

The current ALHC Sharpe Ratio is -0.02, which is lower than the CLOV Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of ALHC and CLOV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ALHC vs. CLOV - Drawdown Comparison

The maximum ALHC drawdown since its inception was -83.61%, smaller than the maximum CLOV drawdown of -97.19%. Use the drawdown chart below to compare losses from any high point for ALHC and CLOV.


Loading charts...

Drawdown Indicators


ALHCCLOVDifference

Max Drawdown

Largest peak-to-trough decline

-83.61%

-97.19%

+13.58%

Max Drawdown (1Y)

Largest decline over 1 year

-44.95%

-55.50%

+10.55%

Max Drawdown (3Y)

Largest decline over 3 years

-50.33%

-64.73%

+14.40%

Max Drawdown (5Y)

Largest decline over 5 years

-80.44%

-94.24%

+13.80%

Current Drawdown

Current decline from peak

-50.42%

-80.72%

+30.30%

Average Drawdown

Average peak-to-trough decline

-51.39%

-76.63%

+25.24%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.71%

29.71%

-14.00%

Volatility

ALHC vs. CLOV - Volatility Comparison

Alignment Healthcare Holdings, LLC (ALHC) has a higher volatility of 30.96% compared to Clover Health Investments, Corp. (CLOV) at 17.95%. This indicates that ALHC's price experiences larger fluctuations and is considered to be riskier than CLOV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ALHCCLOVDifference

Volatility (1M)

Calculated over the trailing 1-month period

30.96%

17.95%

+13.01%

Volatility (6M)

Calculated over the trailing 6-month period

55.04%

43.40%

+11.64%

Volatility (1Y)

Calculated over the trailing 1-year period

61.26%

70.02%

-8.76%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

64.90%

76.67%

-11.77%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

64.61%

85.23%

-20.62%

Dividends

ALHC vs. CLOV - Dividend Comparison

Neither ALHC nor CLOV has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ALHC vs. CLOV - Financials Comparison

This section allows you to compare key financial metrics between Alignment Healthcare Holdings, LLC and Clover Health Investments, Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

ALHC vs. CLOV - Profitability Comparison

The chart below illustrates the profitability comparison between Alignment Healthcare Holdings, LLC and Clover Health Investments, Corp. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

ALHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Alignment Healthcare Holdings, LLC reported a gross profit of -144.48M and revenue of 1.34B. Therefore, the gross margin over that period was -10.8%.

CLOV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Clover Health Investments, Corp. reported a gross profit of 692.13M and revenue of 749.19M. Therefore, the gross margin over that period was 92.4%.

ALHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Alignment Healthcare Holdings, LLC reported an operating income of 42.10M and revenue of 1.34B, resulting in an operating margin of 3.2%.

CLOV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Clover Health Investments, Corp. reported an operating income of 27.33M and revenue of 749.19M, resulting in an operating margin of 3.7%.

ALHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Alignment Healthcare Holdings, LLC reported a net income of 36.56M and revenue of 1.34B, resulting in a net margin of 2.7%.

CLOV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Clover Health Investments, Corp. reported a net income of 27.33M and revenue of 749.19M, resulting in a net margin of 3.7%.


Frequently Asked Questions


ALHC and CLOV have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ALHC has higher volatility (30.96%) compared to CLOV (17.95%). In terms of maximum drawdown, ALHC dropped -83.61% vs CLOV's -97.19%.

CLOV currently has the higher Sharpe Ratio (0.69 vs -0.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ALHC and CLOV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer